ReviewPublished 12 October 2026Progress in research on gut microbiota regulation of tumorigenesis, progression, and therapeutic response via inflammatory cytokinesYan Liu · Dan Zang · Jun ChenFrontiers in Immunologydoi 10.3389/fimmu.2026.1922678
Original ResearchPublished 12 October 2026SCD1 inhibition promotes lipid peroxidation and enhances anti-PD-1 response in triple-negative breast cancerQuentin Herrera Garfia · Aurélien Azam · Eric Bonneil · Laetitia Montero-Ruiz · Mohsen Momeni · Mohammad Farran · Robin Jehay · Nor Eddine SounniFrontiers in Immunologydoi 10.3389/fimmu.2026.1843935
Case ReportPublished 9 October 2026Durable partial response with low-dose, intermittent nivolumab in combination with gemcitabine for high PD-L1 metastatic triple-negative breast cancer: a case reportPo Lin Ooi · Jamin Munchar Elias · Francis Yew Fu TiengFrontiers in Oncologydoi 10.3389/fonc.2026.1964934
Original ResearchPublished 9 October 2026Adverse reactions of immune checkpoint inhibitors combined with acetaminophen/non-steroidal anti-inflammatory drugs (NSAIDs): a pharmacovigilance analysis of drug–drug interactionsXiayang Ren · Lihui Xue · Yanfeng Wang · Jian XiaoFrontiers in Pharmacologydoi 10.3389/fphar.2026.1833275
ReviewPublished 23 September 2026Immunosuppressive cell populations as potential drivers of extrinsic immune checkpoint inhibition resistance in clear cell renal cell carcinomaUsman Humayun TemuriOncology Reviewsdoi 10.3389/or.2026.1953850
Case ReportPublished 4 September 2026Case Report: Pembrolizumab–induced myasthenia gravis with isolated anti-titin antibody positivity after thymectomy for thymomaJu Hye Kim · Ji Yeon Chung · Jeong Bin BongFrontiers in Drug Discoverydoi 10.3389/fddsv.2026.1932554
Mini ReviewPublished 22 July 2026Leveraging ZBP1 signaling for cancer immunotherapyParth Desai · Chunxia Wen · Siddharth BalachandranFrontiers in Cell Deathdoi 10.3389/fceld.2026.1841599
ReviewPublished 28 May 2026The interplay between bile acid metabolism and gut microbiome in biliary tract cancersIfeoma Ike · Farzad Teymouri · Christiana Crook · Sofia Guzman · Max Hazeltine · Dani Castillo · Daneng Li · Gagandeep BrarFrontiers in Microbiomesdoi 10.3389/frmbi.2026.1774429
